Company: Arch Oncology
Job title: Vice President, Research
Arun Kashyap, Ph.D. has over 20 years of experience in biologics drug discovery and leading projects from inception through preclinical development.
Dr. Kashyap serves as Vice President, Research of Arch Oncology. Prior to joining, he served as Senior Director, Protein Science at Dren Bio, where he led internal and external research for early-stage research programs. Earlier, he was Director, Antibody Discovery for Compugen USA, Inc., where he led therapeutic antibody discovery and engineering, development of platform technologies, and target selection activities. Previously, he was Principal Scientist at Protagonist Therapeutics, where he led the discovery of structured peptides for oral delivery in the treatment of inflammatory diseases. Earlier, he was Founding Scientist at Sea Lane Biotechnologies, where he held positions of increasing responsibility in antibody technology development and its application to infectious disease and oncology therapeutics.
AO-176, a highly differentiated CD47-targeting antibody for the treatment of cancers 10:00 am
Download The Full Event Guide Read more
day: Day One